Contact Us

Use the form on the right to contact us.

You can edit the text in this area, and change where the contact form on the right submits to, by entering edit mode using the modes on the bottom right. 

PO Box 25685
Scottsdale, AZ 85255

+1.480.922.3244

FeibusTech: market insight & analysis. Influencer, analyst in IoT, digital health/fitness, wearables, connected car, smart home, privacy/security. Columnist for Tech section of USA TODAY and Fortune.

FeibusTech is brought to you by TechKnowledge Strategies, which has been providing clear, critical and independent insight to technology buyers and suppliers for more than a decade.  TechKnowledge offers a mix of business acumen with a discerning grasp of technology and a savvy honed by years of hands-on experience. If you have questions, TechKnowledge has answers.

FeibusTech Blog

Filtering by Tag: diabetes

Post CES 'Most Mentioned' and More

Mike Feibus

Following CES 2018, I have plenty to explore in healthtech, especially the design, metrics, and integrations on the verge with wearables, hearables, and other health tech trends. I’ll be touching on insights with Samsung and MobileHealth emergency response system.

Pay attention to directional changes in the health sector in regards to diabetes & hearing aids.

Non-intrusive data collection is huge, but more importantly, what consumers can gain from the metrics without the data overload.

 

Notice the twitter ‘most mentioned’ - if you’re on twitter, follow me here for updates.

SymplurCES_2018JanFINAL.png

Plus an honorable mention in DigiObs TOP 15 INFLUENCERS:

digiobs ces 2018Jan nuFINALpng.png

Will Your Doc Ever Prescribe a Fitbit?

Mike Feibus

Validic co-founder and CEO Drew Schiller is in a great position to answer that question, because his company is the go-to liaison between electronic medical records and data flowing from wearables and other connected devices. In this latest FTInsights video interview, Drew shares his thoughts on the state of wearables in health and wellness, and the future for connected devices in the clinical workflow.

First 'Artificial Pancreas' Comes to Market

Mike Feibus

Credit: Medtronic

Credit: Medtronic

The first so-called artificial pancreas systems – wearable devices that take charge of the crucial process of measuring glucose and delivering insulin –  are now beginning to come to market.

That’s welcome news for the nation’s 30 million diabetics, who stand not only to get some relief from the seemingly incessant stream of lancets, test strips and syringes, but also to stay healthier. That’s because an artificial pancreas can keep the disease on a tighter leash than they can, by testing more frequently and delivering more precise insulin doses.

That’s not only important for patients, but could ease strains on the nation's healthcare system.

Read my entire column in the Tech section of USA Today HERE.

Diabetes Care Joins the Digital Age. Finally

Mike Feibus

Wearables and other connected devices have been available to help treat chronic conditions like asthma and heart disease for a while now. But thus far, the nation’s 30 million diabetics largely have been ignored. They haven’t seen much to help them to improve their health or reduce the daily grind of finger pricks and needle pokes.

The $2.5 billion connected-care industry may be off to a late start in diabetes, but it’s making up for lost time. A new breed of connected glucometers, insulin pumps and smartphone apps is hitting the market that promise to make it easier for diabetics to manage the slow-progressing disease and keep them motivated with feedback and support. Startups and multinationals alike plan to showcase the technology this week in Las Vegas at the industry’s flagship health-tech show, produced by the Health Information and Management Systems Society, or HIMSS, industry group.

And in as little as two years, the industry plans to take charge of the entire uncomfortable, time-consuming routine of checking and regulating blood-sugar levels with something called an artificial pancreas. Such systems mimic the functions of a healthy pancreas by blending continuous glucose monitoring, remote-controlled insulin pumps and artificial intelligence to maintain healthy blood-sugar levels automatically.

Read my entire column in the Tech section of USA TODAY.